Www.global-campaign.org Good Participatory Practice UNAIDS & AVAC Document Pauline Irungu Global Campaign for Microbicides.

Slides:



Advertisements
Similar presentations
Do we need a GN of NGOs? Yes! (as far as participation in the GN does not reduce/affect involvement in the GP/DRR) The GN should build on existing networks.
Advertisements

Delivering as One UN Albania October 2009 – Kigali.
11 Scaling Up World Bank Group Engagement with Civil Society: A Strategic Priorities Paper Civil Society Team EXTIA.
Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
Thematic evaluation on the contribution of UN Women to increasing women’s leadership and participation in Peace and Security and in Humanitarian Response.
Global Prevention Research Advocacy Partnerships Good Participatory Practice Initiative In November 2007, UNAIDS and AVAC published Good Participatory.
Stakeholder Engagement and Good Participatory Practices for Global Clinical Trials: Developing Tools and Models for the 21st Century Kathleen M. MacQueen,
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials Second Edition 2011.
Developing a Strategic Communications Plan. Overview This session will cover how to: Outline team functions and chain of command Identify key stakeholders.
Developing and Testing a Framework and Approach for Measuring Success in Repositioning Family Planning Nicole Judice Elizabeth Snyder MEASURE Evaluation.
Summarizing Community-Based Participatory Research: Background and Context for the Review Lucille Webb, MEd Eugenia Eng, DrPH Alice Ammerman, DrPH Meera.
Comprehensive M&E Systems
Student Assessment Inventory for School Districts Inventory Planning Training.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS AND PROGRAMMES presented by Faizal Parish Regional/Central Focal Point GEF NGO.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Preparing for and Disseminating Study Results. Overview This session will cover how to: Develop and implement a dissemination plan Correctly time the.
Organization Mission Organizations That Use Evaluative Thinking Will Develop mission statements specific enough to provide a basis for goals and.
From Evidence to Action: Addressing Challenges to Knowledge Translation in RHAs The Need to Know Team Meeting May 30, 2005.
‘Every Newborn’ Country Consultations Country Consultation Objectives Main objective: To provide an opportunity to engage key stakeholders in participatory.
The Institute of Internal Auditors
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Overview of NIPP 2013: Partnering for Critical Infrastructure Security and Resilience October 2013 DRAFT.
CPTR Key Accomplishments: Research Resources Group October 3, 2012.
The Global Fund- structure, function and evolution February 18, 2008.
What Makes a Successful Trial? MorenikeUkpong Nigeria HIV Vaccine and Microbicide Advocacy Group.
Toolkit for Mainstreaming HIV and AIDS in the Education Sector Guidelines for Development Cooperation Agencies.
The Measurement and Evaluation of the PPSI Oregon Pilot Program Paint Product Stewardship Initiative Portland, Oregon December 10, 2009 Matt Keene Office.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Tracking of GEF Portfolio: Monitoring and Evaluation of Results Sub-regional Workshop for GEF Focal Points Aaron Zazueta March 2010 Hanoi, Vietnam.
UNITED NATIONS Population Unit ECONOMIC COMMISSION FOR EUROPE Road Maps for Mainstreaming Ageing  Fiona Willis-Núñez.
What Do We Mean by Community?
The Global Fund - Proposal Process & Round 8 February 19, 2008.
Operational Plan for UNAIDS Action Framework: Addressing Women, Girls, Gender Equality and HIV February 3, 2010.
Margo Michaels, MPH Executive Director, ENACCT Co PI, Communities as Partners in Cancer Clinical Trials, R13-HS Panel on Use and Implementation of.
Africa Health Workforce Platform & Observatory Presentation to the 1st conference of the Asia-Pacific Action Alliance on HRH (AAAH): October 2006.
HEADING HOME: Kitsap Homeless Housing Plan 2008 Update Kitsap Regional Coordinating Council.
April_2010 Partnering initiatives at country level Proposed partnering process to build a national stop tuberculosis (TB) partnership.
Coastal Adaptation in the tourism industry of the Seychelles Mr. Alain De Comarmond Ministry of Environment and Natural Resources Republic of Seychelles.
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials 2011, Second Edition.
1 Status of PSC recommendations (January December 2007) Portfolio Committee on Public Service and Administration 14 March 2008.
December_2009 Partnership building. December_2009 Partnership building within the partnering process COREGROUPCOREGROUP FORMAL LAUNCH $ $ $ $ $ cost centre.
The Global Fund and Southern Africa A review of the structures and grants in southern Africa.
TRUE PATIENT & PARTNER ENGAGEMENT HOW IS IT DONE?.
Using the FRP to Enhance Georgia’s Leadership Program May 9, 2006 Stephanie Busch P 2 AD.
15 step process for developing an inclusive and widely supported integrated RH/HIV Proposal R8 Richard Matikanya International HIV/AIDS Alliance.
ACCOUNTABILITY AND MONITORING IN HEALTH INITIATIVE PUBLIC HEALTH PROGRAM Capacity Building Consultation 5 – 7 June, 2012 Istanbul, Turkey.
Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
Montreux, Switzerland, March 2007 New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications New Data on Male Circumcision and.
Tracking national portfolios and assessing results Sub-regional Workshop for GEF Focal Points in West and Central Africa June 2008, Douala, Cameroon.
Advocate Bethany Community Health Fund Grantmaking as a Collaborative Model to Address Social Determinants of Health September 25, 2015 Ina N. Owens, Vice.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Hankins UNAIDS Mexico Aug 6/08 Women and clinical trials: Where have we been and where are we going? ‘Women and clinical trials: where have we been and.
Vito Cistulli - FAO -1 Damascus, 2 July 2008 FAO Assistance to Member Countries and the Changing Aid Environment.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
Country and community preparedness: Community Involvement in Clinical Trials Global Campaign for Microbicides.
Economies of Scale: A National Network of Quitlines Suzy McDonald, Program Consultant, Tobacco Control Programme, Health Canada.
Global Partnership for Enhanced Social Accountability (GPESA) December 19, 2011 World Bank.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Action Points. SO1 Norms and Standards sub-group Immediate next steps: prepare preamble / copy edit and fact checking (EG) Develop and implement a dissemination.
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
Internal Audit Quality Assessment Guide
G ENDER A SSESSMENTS OF THE N ATIONAL R ESPONSES TO HIV A SUMMARY: Learning from the application of the UNAIDS Gender Assessment Tool in Eleven Countries.
GCM Community Involvement Tool Kit Glenburn Lodge, Muldersdrift, South Africa November 27-28, 2007.
GCP (GOOD CLINICAL PRACTISE)
Supporting community action on AIDS in developing countries ‘Evaluating HIV and AIDS-related advocacy’ Skills Building Session International.
Civil Society Participation and Contribution to the UNCAC Review Process Towards Transparency – TI National Contact Vietnam UNCAC Self Assessment Process:
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials 2011, Second Edition Note to trainer/presenter: You may use all or.
SRH & HIV Linkages Agenda
What is the role of a CAB in biomedical HIV prevention research in South Africa? CABS are the most common mechanism for engaging communities in research.
Presentation transcript:

Good Participatory Practice UNAIDS & AVAC Document Pauline Irungu Global Campaign for Microbicides

Goals of the GPP  “These Good Participatory Practice guidelines aim to provide systematic guidance on the roles and responsibilities of entities funding and conducting biomedical HIV prevention trials towards participants and their communities”  And to elevate the GPP process to the same level as other normative guidance documents (GCP, etc.)  The GPP document has the potential to be the basis for and/or a tool in community advocacy around HIV prevention research.

Overview of the Process Follow-up to recommendations of the 2005 UNAIDS global consultation Creating Effective Partnerships for HIV Prevention Trials :  An interdisciplinary, international working group was convened.  Guidelines were drafted to provide minimum standards, common principles to guide HIV prevention trials, and systematic ways of evaluating engagement of community before, during, and after trials are completed.  AVAC, UNAIDS and other collaborators worked to develop the current pre-publication version of GPP over the past 12 months.  The draft was systematically reviewed based on input from researchers, trial sponsors, community members, advocates, and the public, through comments, interviews, and listserve postings for a wide range of stakeholders.

The GPP Audience Those involved in designing, financing and executing clinical trials research, including: –Investigators –Research staff –Pharmaceutical industry sponsors –Foundations –Government-supported research networks –NGO research sponsors

What the GPP Document Does  Outlines ten core principles, describes essential issues and activities and illustrates these throughout the research life-cycle.  Provides guidance to researchers, funders, and communities on the conduct of prevention trials.  Defines minimum standards and common principles to enhance existing research programmes and assist in the development of new HIV prevention trials globally.  Describes systematic ways of evaluating engagement of the community before, during, and after a trial is completed.  Lays a foundation for locally-driven processes which could address critical questions and issues.

Formative research with community Protocol development and review Institutional review boards, ethics committees, and other regulatory mechanisms Informed consent Standard of prevention and access to care Policy on coverage for research-related harm Community engagement/involvement/education plan Communications plan Monitoring and issues management plan Community advisory mechanisms Community involvement runs through research life cycle: from site selection to technology access GPP Essential Issues and Activities

What the GPP Doesn’t Do The GPP aims to provide guidelines on laying the framework for participatory practice and what should be considered. It does not tell you HOW to do community engagement.

Critique of the GPP Does not explicitly recognize the limitations of the values framework it advances. Does not acknowledge that research is taking place in the context of inequality. Needs to be realistic about the fact that power imbalances between North & South, researchers & participants, and study staff & CABs exists and will remain. Must include need for country adaptation. GPP is too aspirational and needs to acknowledge these imbalances that exist in the field and accept incremental progress.

The Future of the GPP UNAIDS and AVAC are collecting comments on the GPP including feedback from 40 interviews with civil society members and leaders. The GPP will be released as a living document. AVAC is committed to putting together a civil society response to the document and to advocate for changes based on that response. –As part of this process they will hold a moderated listserv discussion on the GPP and plan to put out a Request for Proposals, giving small grants to capture further input.

The AVAC RFP on GPP In December 2007, AVAC will launch a Request for Proposals (“RFP”) for community feedback on and engagement with the GPP document The RFP is a first step in attempting to generate community feedback and identify the ways in which the document can become a useful tool.

Who is Eligible? The CC-GPP Awards will be made to non-profit groups and organizations (NGO) who engage in community-based work. Community advisory mechanisms which are independent or which have been established in collaboration with research entities are also eligible for funding.

What Kind of Activities Will the RFP Support? One-day or half-day stakeholder consultations on some or all sections of the existing GPP document Local meetings with key stakeholders to get input into the GPP document as a guidance tool Pilot use in relation to an ongoing or planned trial in a community Retrospective analyses of past trial-related advocacy or scenarios (how the document would or would not have helped in the situation)

Discussion Points One of the goals of the GPP is to be institutionalized as a normative document (similar to GCP, GLP, etc.). Is that what we want? Is it time well spent? AVAC is considering next steps (RFP). Do we have thoughts about how the RFP could be better contoured? Would it be more useful to have some money available for other activities related to the GPP? Looking back at the unmet needs we mapped, which of these needs does the GPP address? Which does it not address (remain as a gap)?